KDR and pancreatic neoplasm: In addition, VEGF-dependent angiogenesis requires p38MAPK activation, and VEGFR blocker (Sorafenib), which has shown benefit in patients with HCC, induces cells apoptosis through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways in human pancreatic cancer cells [26].